Prolonged ischemic conduction failure after reperfusion in diabetic nerve

Area of Science:

• Neuroscience
• Diabetology
• Vascular Biology

Background:

• Diabetic nerves are morphologically vulnerable to ischemia/reperfusion, despite physiological resistance to ischemic conduction failure (RICF).
• Understanding the sequence of ischemic conduction failure and recovery in diabetic nerves post-reperfusion is crucial.

Purpose of the Study:

• To investigate the effects of varying ischemia durations on nerve conduction and recovery in streptozocin-induced diabetic rats.
• To compare the recovery patterns of diabetic nerves versus control nerves after ischemia and reperfusion.

Main Methods:

• Sciatic-tibial nerve conduction was measured in diabetic and control rats before, during (30-180 min), and after reperfusion (up to 1 week) of ischemia.
• Compound muscle action potential (CMAP) amplitude recovery was assessed.
• Axonal degeneration was evaluated following reperfusion.

Main Results:

• Diabetic rats confirmed RICF during ischemia.
• Control nerves recovered CMAP amplitude immediately after ischemia ≤120 min, but delayed recovery after 150 min.
• Diabetic nerves showed delayed recovery even after 1-hour ischemia, with 75 min ischemia causing delayed or no CMAP recovery and 90-120 min leading to axonal degeneration.

Conclusions:

• Diabetic nerves exhibit delayed recovery from ischemic conduction failure after shorter ischemia durations compared to control nerves.
• Ischemia of 60-75 min causes prolonged conduction failure in diabetic nerves, unlike control nerves requiring 150 min.
• Patients with diabetic neuropathy may face a worse prognosis when nerve ischemia occurs due to impaired recovery.